Wire Stories

Category Added in a WPeMatico Campaign

news_6

Results from First Combination Trial of ENHERTU® and Immune Checkpoint Inhibitor in Patients with HER2 Expressing Metastatic Breast Cancer Presented at the 2020 San Antonio Breast Cancer Symposium

news_6

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Splunk Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – SPLK